300 related articles for article (PubMed ID: 9039923)
1. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
2. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
3. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417
[TBL] [Abstract][Full Text] [Related]
4. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
5. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
6. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
7. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
8. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
Jamshidi F; De Fazio SR; Gozzo JJ
Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
[TBL] [Abstract][Full Text] [Related]
9. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.
Hale D; Gottschalk R; Maki T; Monaco AP
Transplant Proc; 1998 Aug; 30(5):2432-4. PubMed ID: 9723527
[TBL] [Abstract][Full Text] [Related]
10. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow.
Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905
[TBL] [Abstract][Full Text] [Related]
11. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
[TBL] [Abstract][Full Text] [Related]
12. Marked prolongation of rat skin xenografts induced by intrathymic injection of xenogeneic splenocytes and a short course of rapamycin in antilymphocyte serum-treated mice.
Dono K; Wood ML; Ozato H; Otsu I; Gottschalk R; Maki T; Monaco AP
Transplantation; 1995 Apr; 59(7):929-32. PubMed ID: 7709451
[TBL] [Abstract][Full Text] [Related]
13. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
14. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
Kanamoto A; Monaco AP; Maki T
Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
[TBL] [Abstract][Full Text] [Related]
15. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
[No Abstract] [Full Text] [Related]
16. Potent skin allograft survival prolongation using a committed progenitor fraction of bone marrow in mice.
Akpinar E; Craighead N; Smoot D; Hale DA
Transplantation; 2004 Aug; 78(3):383-91. PubMed ID: 15316366
[TBL] [Abstract][Full Text] [Related]
17. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
[TBL] [Abstract][Full Text] [Related]
18. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow.
Anam K; Akpinar E; Craighead N; Black AT; Hale DA
Transplantation; 2004 Nov; 78(9):1290-8. PubMed ID: 15548965
[TBL] [Abstract][Full Text] [Related]
19. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1992 Mar; 53(3):521-7. PubMed ID: 1549842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
